als erwartet.
Total solide 40% Chance. Kurs derzeit 17,50, Kursziel mindestens 25 Dollar bis März 2003. Für alle die es konservativ mögen und ein bisschen warten können.
Gruss E.
King Pharma earns grow, top expectations (7:40 AM ET) King Pharmaceuticals(KG: news, chart, profile)reported third-quarter earnings that rose over year-earlier levels and topped Wall Street expectations and said it remained "comfortable" with current earnings projections for the fourth quarter and for 2003. Net earnings for the quarter ending September, excluding non-recurring items, were $84.7 million, or 35 cents a share, up from last year's 28 cents a share. Total revenue rose 37 percent to $315.7 million. Analysts surveyed by Thomson First Call had been expecting earnings of 34 cents a share and revenue of $306.8 million, on average. The branded drug maker's stock closed Friday down 69 cents at $17.
|